Literature DB >> 27928154

Rheumatoid arthritis: Anti-TNF agents go head-to-head.

Sarah Onuora.   

Abstract

Entities:  

Year:  2016        PMID： 27928154     DOI： 10.1038/nrrheum.2016.206

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.

Authors:  Josef S Smolen; Gerd-Rüdiger Burmester; Bernard Combe; Jeffrey R Curtis; Stephen Hall; Boulos Haraoui; Ronald van Vollenhoven; Christopher Cioffi; Cécile Ecoffet; Leon Gervitz; Lucian Ionescu; Luke Peterson; Roy Fleischmann
Journal:  Lancet       Date:  2016-11-15       Impact factor: 79.321
  1 in total
  3 in total

Review 1.  Metabolic signatures of T-cells and macrophages in rheumatoid arthritis.

Authors:  Cornelia M Weyand; Markus Zeisbrich; Jörg J Goronzy
Journal:  Curr Opin Immunol       Date:  2017-05-21       Impact factor: 7.486

Review 2.  Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity.

Authors:  Leila Mohammadnezhad; Mojtaba Shekarkar Azgomi; Marco Pio La Manna; Guido Sireci; Chiara Rizzo; Giusto Davide Badami; Bartolo Tamburini; Francesco Dieli; Giuliana Guggino; Nadia Caccamo
Journal:  Cells       Date:  2022-05-17       Impact factor: 7.666

Review 3.  The Potential Role of Trained Immunity in Autoimmune and Autoinflammatory Disorders.

Authors:  Rob J W Arts; Leo A B Joosten; Mihai G Netea
Journal:  Front Immunol       Date:  2018-02-20       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.